Ernexa Therapeutics Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | $3.8M | $6.9M | $2.5M |
| FY2019 | — | $9.7M | $3.2M |
| FY2020 | $532.0K | $7.7M | $777.0K |
| FY2021 | — | $25.5M | $17.0M |
| FY2022 | — | $12.1M | $11.4M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | $3.8M | $6.9M | $2.5M |
| FY2019 | — | $9.7M | $3.2M |
| FY2020 | $532.0K | $7.7M | $777.0K |
| FY2021 | — | $25.5M | $17.0M |
| FY2022 | — | $12.1M | $11.4M |